EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Long-term Satisfaction with CO2 Laser Treatment for Moderate to Major Rhinophyma: A Single-centre Study

Berta Olafsdottir, William Jebril, Philip Curman, Etty Bachar-Wikström, Jakob D Wikström

Acta Dermato-Venereologica · 2025

DOI: 10.2340/actadv.v105.41335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Dermato-Venereologica, 2025. Verfasst von Berta Olafsdottir und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology and Venereology Division, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Rhinophyma, Lasers, Gas, Patient Satisfaction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rhinophyma, a severe manifestation of rosacea, predominantly affects Caucasian males aged 50–70 and is characterized by thickening and enlargement of the nasal skin. The condition can seriously both impact cosmetic appearance and obstruct nasal breathing. While its appearance is distinct, conditions such as basal cell carcinoma can mimic it, complicating diagnosis. Treatment options for rhinophyma range from medical therapies to surgical interventions, with CO2 laser resurfacing emerging as the gold standard due to its precision and minimal blood loss. This retrospective case series evaluates the long-term efficacy and patient satisfaction of CO2 laser treatment in 11 male patients treated between 2015 and 2023 at the Karolinska University Hospital. The results revealed sustained positive outcomes, with 92% of patients reporting high satisfaction and 55% experiencing improved nasal airflow post-procedure. Despite some instances of hypopigmentation and scarring, no major side effects were reported. The study supports CO2 laser treatment as a safe and effective option for moderate to major rhinophyma in Caucasian male patients with Fitzpatrick skin types I–III. The importance of considering skin type, where extra caution must be employed when treating skin types IV–VI, should be emphasized as the treatment

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhinophymaLasers, GasPatient SatisfactionHumansMaleAgedRetrospective StudiesMiddle AgedTreatment OutcomeTime FactorsLaser TherapySeverity of Illness Index

Autor:innen und Institutionen

  • Dermatology and Venereology Division, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden.
  • Dermatology and Venereology Division, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden; Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden.
  • Dermatology and Venereology Division, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden; Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Epidem…
  • Dermatology and Venereology Division, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden; Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden; Nordiska kliniken, Stockholm…

Zitieren

APA

Olafsdottir, B., Jebril, W., Curman, P., Bachar-Wikström, E., & Wikström, J. D. (2025). Long-term Satisfaction with CO2 Laser Treatment for Moderate to Major Rhinophyma: A Single-centre Study. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v105.41335

Vancouver

Olafsdottir B, Jebril W, Curman P, Bachar-Wikström E, Wikström JD. Long-term Satisfaction with CO2 Laser Treatment for Moderate to Major Rhinophyma: A Single-centre Study. Acta Dermato-Venereologica. 2025. doi:10.2340/actadv.v105.41335

BibTeX
@article{Olafsdottir2025,
  author = {Olafsdottir, Berta and Jebril, William and Curman, Philip and Bachar-Wikström, Etty and Wikström, Jakob D},
  title = {Long-term Satisfaction with CO2 Laser Treatment for Moderate to Major Rhinophyma: A Single-centre Study},
  journal = {Acta Dermato-Venereologica},
  year = {2025},
  doi = {10.2340/actadv.v105.41335}
}
Kostenlos starten →